Bumper Offer - Urjas oil Just @ Rs. 1
Nasivion S Nasal Spray is a prescription medicine that is available as a Spray. It is primarily used for the treatment of Dehydration. Nasivion S Nasal Spray also has some secondary and off-label uses. These are listed below.
The optimal dosage of Nasivion S Nasal Spray is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Nasivion S Nasal Spray as well, which are listed below. These side effects of Nasivion S Nasal Spray are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Nasivion S Nasal Spray's effect is Safe during pregnancy and Safe for lactating mothers. It is important to know if Nasivion S Nasal Spray has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Nasivion S Nasal Spray related warnings section.
Some other conditions that can be affected by Nasivion S Nasal Spray are listed in the contraindications section below.
Drug reaction of Nasivion S Nasal Spray with other medicines has been reported. See below for a complete list.
You should also be aware that Nasivion S Nasal Spray is safe while driving, and is addiction.
Nasivion S Nasal Spray is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Nasivion S Nasal Spray is used -
Moderate
Mild
Is the use of Nasivion S Nasal Spray safe for pregnant women?
The effects of Nasivion on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Nasivion S Nasal Spray safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Nasivion for breastfeeding women are not known.
What is the effect of Nasivion S Nasal Spray on the Kidneys?
Nasivion may have mild side effects on the kidneys.
What is the effect of Nasivion S Nasal Spray on the Liver?
Nasivion may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Nasivion S Nasal Spray on the Heart?
You can take Nasivion without any fear of damage to the heart.
Nasivion S Nasal Spray should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Nasivion S Nasal Spray unless your doctor advises you to do so -
Is this Nasivion S Nasal Spray habit forming or addictive?
Nasivion S Nasal Spray is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Nasivion S Nasal Spray does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, the use of Nasivion S Nasal Spray is considered safe.
Is it able to treat mental disorders?
Nasivion S Nasal Spray is unable to treat or cure mental disorders.
Interaction between Food and Nasivion S Nasal Spray
Information is not available on the interaction of any foods with Nasivion S Nasal Spray, due to a lack of research on this.
Interaction between Alcohol and Nasivion S Nasal Spray
No research has been done on this till date. Therefore, it is not known what the effect of taking Nasivion S Nasal Spray with alcohol will be.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Allegra® (fexofenadine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 163,166
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 566
